USO COMBINADO DE TOCILIZUMABE E CÉLULAS-TRONCO MESENQUIMAIS NO TRATAMENTO DA COVID-19 – RELATO DE CASO
Main Authors: | A.C. Senegaglia, C.L.K. Rebelatto, C.L. Franck, J.S. Lima, D.R. Daga, P. Shigunov, A.P. Azambuja, E.G. Bana, A.C. Dominguez, P.R.S. Brofman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137920312402 |
Similar Items
-
Isolamento e caracterização de células mesenquimais do tecido adiposo de cães
by: L.F.L. Patricio, et al.
Published: (2013-08-01) -
The epigenetic modifiers 5-aza-2'-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells
by: J. Zych, et al.
Published: (2013-05-01) -
The epigenetic modifiers 5-aza-2'-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells
by: J. Zych, et al.
Published: (2013-05-01) -
Caracterização da expressão de DZIP1 e PUM2 em células-tronco mesenquimais humanas durante o processo de diferenciação celular
by: Shigunov, Patrícia
Published: (2016) -
Combined Use of Tocilizumab and Mesenchymal Stromal Cells in the Treatment of Severe Covid-19: Case Report
by: Alexandra Cristina Senegaglia, et al.
Published: (2021-06-01)